Filter
1463
Filtered Results: 1463
Text search:
diagnóstico
molecular
Featured
Recommendations
170
New Publications
274
Language
Document type
No document type
661
Guidelines
342
Studies & Reports
233
Manuals
82
Strategic & Response Plan
73
Fact sheets
39
Training Material
12
Situation Updates
12
Resource Platforms
6
Infographics
2
Brochures
1
Countries / Regions
India
78
Latin America and the Carribbean
63
Western and Central Europe
53
Brazil
51
Global
44
Africa
35
Eastern Europe
35
Colombia
29
Kenya
25
South Africa
21
Peru
21
Ethiopia
19
Tanzania
18
Argentina
18
West and Central Africa
17
El Salvador
16
Venezuela
16
Russia
16
Germany
15
East and Southern Africa
15
Paraguay
14
Mozambique
13
Senegal
11
Uganda
11
Malawi
11
Sierra Leone
10
Nigeria
10
Bolivia
10
Chile
10
South–East Asia Region
10
Asia
10
Philippines
9
Zambia
9
Ecuador
9
Angola
9
Liberia
8
Rwanda
8
Ukraine
8
Bangladesh
7
Ghana
6
Middle East and North Africa
6
Congo, Democratic Republic of
5
Zimbabwe
5
Nepal
5
Namibia
5
Eastern Europe and Central Asia
5
Spain
5
USA
4
Cameroon
4
Indonesia
4
Myanmar / Burma
4
Western Pacific Region
4
Guinea
3
Burkina Faso
3
Haiti
3
Pakistan
3
Benin
3
Eswatini/ Swaziland
3
Uruguay
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Syria
2
Cambodia
2
Dominican Republic
2
Honduras
2
Guatemala
2
Georgia
2
North America
2
Mali
1
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Jordan
1
Turkey
1
Chad
1
Thailand
1
Gambia
1
China
1
Mauritania
1
Cuba
1
Botswana
1
Libya
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Italy
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Tajikistan
1
Estonia
1
Romania
1
Turkmenistan
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
194
Pharmacy & Technologies
60
Public Health
53
Key Resources
19
Women & Child Health
18
Capacity Building
4
Toolboxes
TB
367
COVID-19
230
AMR
94
NTDs
90
HIV
75
Rapid Response
66
Mental Health
60
Ebola
34
Zika
28
Planetary Health
25
Pharmacy
23
NCDs
16
Polio
12
Refugee
12
Caregiver
9
Cholera
8
Global Health Education
6
Specific Hazards
5
Disability
4
Natural Hazards
4
Health Financing Toolbox
4
Conflict
3
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
Update, 23 de junio de 2022
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
January 2020 to December 2021
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Revised and expanded version of the Guidelines
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom...
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
